Intravenous amino acids may mediate the adverse effect of early parenteral nutrition on mortality in critically ill patients requiring mechanical ventilation: A post hoc analysis of the NEED trial

JPEN J Parenter Enteral Nutr. 2023 Feb;47(2):301-309. doi: 10.1002/jpen.2455. Epub 2022 Nov 6.

Abstract

Background: There is controversy regarding the optimal timing of initiating parenteral nutrition (PN) in critically ill patients. We aimed to evaluate the association between early PN and clinical outcomes and explore the mediation effects of different macronutrients in a cohort of mechanically ventilated patients.

Methods: This is a post hoc analysis of the NEED trial aiming to investigate the effect of implementing an evidence-based feeding guideline in newly-admitted critically ill patients. All eligible patients were divided into those who received early PN within the first 3 days of enrollment (early PN) or those who did not (non-early PN). Propensity score matching with a one-to-one nearest neighbor-matching algorithm was applied to control potential confounders. Mediation analysis was used to test the indirect effect of different macronutrients from PN on the relationship between early PN and 28-day mortality.

Results: The propensity score matching created 370 matched pairs of 1154 patients that met the eligibility criteria. Compared with non-early PN, patients receiving early PN had significantly higher 28-day mortality (19.7% vs 12.4%; hazard ratio = 1.904; 95% CI, 1.063-3.410; P = 0.03). Mediation analysis showed that amino acids from early PN mediated 65% (mediation effect = 0.07; 95% CI, 0.02-0.13; P = 0.01) of the detrimental effect of early PN on the 28-day mortality.

Conclusion: Early PN is associated with increased 28-day mortality in critically ill patients requiring invasive mechanical ventilation. The detrimental effect may be mediated by intravenous amino acids from early PN.

Keywords: critical illness; mechanical ventilation; mortality; nutrition support; parenteral nutrition.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids* / adverse effects
  • Critical Illness / therapy
  • Hospital Mortality
  • Humans
  • Parenteral Nutrition / adverse effects
  • Respiration, Artificial*

Substances

  • Amino Acids